2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one CHEMBL1513 BDBM50042235 IRBESARTAN BMS 186295 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
- Hernandez-Olmos, V; Heering, J; Bischoff-Kont, I; Kaps, A; Rajkumar, R; Liu, T; Fürst, R; Steinhilber, D; Proschak, E Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening. ACS Med Chem Lett 12: 1261-1266 (2021)
- Le Bourdonnec, B; Cauvin, C; Meulon, E; Yous, S; Goossens, JF; Durant, F; Houssin, R; Hénichart, JP Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan. J Med Chem 45: 4794-8 (2002)
- Kavitha, CV; Gaonkar, SL; Narendra Sharath Chandra, JN; Sadashiva, CT; Rangappa, KS Synthesis and screening for acetylcholinesterase inhibitor activity of some novel 2-butyl-1,3-diaza-spiro[4,4]non-1-en-4-ones: derivatives of irbesartan key intermediate. Bioorg Med Chem 15: 7391-8 (2007)